- Home
- ABEV vs DXCM Comparison
ABEV vs DXCM Comparison
Compare ABEV & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEV
- DXCM
- Stock Information
- Founded
- ABEV 1885
- DXCM 1999
- Country
- ABEV Brazil
- DXCM United States
- Employees
- ABEV N/A
- DXCM N/A
- Industry
- ABEV Beverages (Production/Distribution)
- DXCM Medical/Dental Instruments
- Sector
- ABEV Consumer Staples
- DXCM Health Care
- Exchange
- ABEV Nasdaq
- DXCM Nasdaq
- Market Cap
- ABEV 33.8B
- DXCM 31.7B
- IPO Year
- ABEV N/A
- DXCM 2005
- Fundamental
- Price
- ABEV $2.18
- DXCM $67.79
- Analyst Decision
- ABEV Hold
- DXCM Strong Buy
- Analyst Count
- ABEV 4
- DXCM 19
- Target Price
- ABEV $2.35
- DXCM $97.42
- AVG Volume (30 Days)
- ABEV 41.5M
- DXCM 6.8M
- Earning Date
- ABEV 10-30-2025
- DXCM 10-30-2025
- Dividend Yield
- ABEV 7.98%
- DXCM N/A
- EPS Growth
- ABEV 2.96
- DXCM N/A
- EPS
- ABEV 0.17
- DXCM 1.43
- Revenue
- ABEV $16,833,014,419.00
- DXCM $4,300,800,000.00
- Revenue This Year
- ABEV $5.86
- DXCM $17.01
- Revenue Next Year
- ABEV $4.97
- DXCM $15.36
- P/E Ratio
- ABEV $12.63
- DXCM $47.39
- Revenue Growth
- ABEV 13.76
- DXCM 9.30
- 52 Week Low
- ABEV $1.76
- DXCM $57.52
- 52 Week High
- ABEV $2.64
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- ABEV 36.86
- DXCM 32.45
- Support Level
- ABEV $2.17
- DXCM $63.53
- Resistance Level
- ABEV $2.21
- DXCM $68.00
- Average True Range (ATR)
- ABEV 0.04
- DXCM 2.75
- MACD
- ABEV -0.02
- DXCM -0.03
- Stochastic Oscillator
- ABEV 7.69
- DXCM 19.66
About ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.